These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1835140)

  • 1. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
    Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity and long-term effectiveness of the hepatitis B vaccine in newborns from HBsAg-positive mothers].
    Torres JM; Bruguera M; Fos E; Mayor A; Hierro FR
    Med Clin (Barc); 1990 Sep; 95(7):247-9. PubMed ID: 2149403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune response to hepatitis B vaccine in neonates born to mothers with various infection status of hepatitis B virus].
    Yin SR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):198-202. PubMed ID: 2805044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of hepatitis B vaccine in premature infants.
    Sanpavat S; Poovorawan Y; Chittinand S; Bhongsvej S; Thaithumyanon P
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):93-5. PubMed ID: 7825032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
    Moyes C; Milne A
    N Z Med J; 1988 Apr; 101(843):162-4. PubMed ID: 2965799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Premature infants and hepatitis B vaccination. Study Group Prevention Neonatal Hepatitis B].
    Del Canho R; Grosheide PM; Gerards LJ; Heijtink RA; Schalm SW
    Tijdschr Kindergeneeskd; 1992 Aug; 60(4):105-11. PubMed ID: 1440551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
    Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
    Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.